Exposure to environmental concentrations of hexachlorobenzene induces alterations associated with endometriosis progression in a rat model. (January 2019)

• Record Type: Journal Article
• Authors: Chiappini, Florencia; Sánchez, Marcela; Miret, Noelia; Cocca, Claudia; Zotta, Elsa; Ceballos, Leandro; Pontillo, Carolina; Bilotas, Mariela; Randi, Andrea
• Is Part Of: Food and chemical toxicology. Volume 123(2019)
• Page Start: 151
• Page End: 161
• Publication Date: 2019-01
• Subjects: Hexachlorobenzene -- Rat endometriosis model -- Vascular endothelial growth factor -- Aryl hydrocarbon receptor -- Cyclooxygenase-2; Toxicology -- Periodicals; Food poisoning -- Periodicals; Food Poisoning -- Periodicals; Toxicology -- Periodicals; Toxicologie -- Périodiques; Intoxications alimentaires -- Périodiques; Food poisoning; Toxicology; Periodicals; Electronic journals; 615.9
• DOI: 10.1016/j.fct.2018.10.056
• Languages: English
• ISSNs: 0278-6915

Abstract

Abstract: Hexachlorobenzene (HCB) is a dioxin-like compound widely distributed and is a weak ligand of the aryl hydrocarbon receptor (AhR). Endometriosis is a disease characterized by growth of endometrial tissue in ectopic sites. Our aim was to investigate the impact of HCB on the endocrine, invasion and inflammatory parameters in a rat endometriosis model surgically induced. Female rats were exposed to HCB (1, 10 and 100 mg/kg b.w.) during 30 days. Results showed that HCB increases endometriotic like-lesions (L) volume in a dose-dependent manner. In L, HCB10 increases microvessel density (immunohistochemistry) and the vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-2) and AhR levels (Western Blot), while HCB1 enhances aromatase expression (Western Blot). In addition, in eutopic endometrium (EU), HCB10/HCB100 augments microvessel density, VEGF and MMP-9 expression, while HCB1/HCB10 increases tumor necrosis factor-α (TNF-α) content in peritoneal fluid (ELISA). Interestingly, both L and EU from HCB-treated rats exhibited higher estrogen receptor α (ERα) (immunohistochemistry) and metalloproteases (MMP)-2 and −9 levels (Western Blot), as well as lower progesterone receptor (PR) expression (immunohistochemistry) than in control rats. Environmentally relevant concentrations of HCB could contribute to abnormal changes associated with endometriosis progression and development. Highlights: HCB increases the lesions volume in a dose-dependent manner. In lesions, HCB enhances microvessel density and VEGF and COX-2 levels. In eutopic endometrium, HCB augments microvessel density, VEGF and MMP-9 expression. In lesions and eutopic endometrium, HCB enhances ERα and metalloproteases expression and decreases PR levels. HCB increases TNF-α content in peritoneal fluid.